Return to search

Kymera Therapeutics inks $102m Series C

Cambridge, Massachusetts-based Kymera Therapeutics Inc., a biotechnology company, has raised $102 million in Series C financing.

Cambridge, Massachusetts-based Kymera Therapeutics Inc., a biotechnology company, has raised $102 million in Series C financing. Biotechnology Value Fund and Redmile Group led the round.

Source: Press Release